Cite
HARVARD Citation
Mastorino, L. et al. (2022). Impact of comorbidities in the response of atopic patients treated with dupilumab: a real‐life study up to 36 weeks. Journal of the European Academy of Dermatology and Venereology. pp. e1021-e1023. [Online].